Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Xtant Medical Holdings Inc shares valued at $30,708,129 were sold by ORBIMED ADVISORS LLC on Apr 10 ’25. At $0.42 per share, ORBIMED ADVISORS LLC sold 73,114,592 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
As published in their initiating research note from BTIG Research on December 05, 2023, Xtant Medical Holdings Inc [XTNT] has been a Buy and the price target has been revised to $2. Analysts at Maxim Group resumed the stock at ‘”a Buy”‘ outlook in a report released in mid November. As of February 14, 2018, Maxim Group has reiterated its “Buy” rating for XTNT.
Analyzing XTNT Stock Performance
On last trading session,, Xtant Medical Holdings Inc [AMEX: XTNT] plunged -1.88% to $0.59. The stock’s lowest price that day was $0.5715, but it reached a high of $0.6435 in the same session. During the last five days, there has been a drop of approximately -12.46%. Over the course of the year, Xtant Medical Holdings Inc shares have jumped approximately 32.91%. Shares of the company reached a 52-week high of $0.7495 on 05/19/25 and a 52-week low of $0.3401 on 04/10/25.
Support And Resistance Levels for Xtant Medical Holdings Inc (XTNT)
According to the 24-hour chart, there is a support level at 0.5590, which, if violated, would cause prices to drop to 0.5293. In the upper region, resistance lies at 0.6310. The next price resistance is at 0.6733. RSI (Relative Strength Index) is 40.89 on the 14-day chart, showing neutral technical sentiment.
Is Xtant Medical Holdings Inc subject to short interest?
Stocks of Xtant Medical Holdings Inc saw a sharp steep in short interest on 2025-05-30 dropping by 35730.0 shares to 24186.0. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 59916.0 shares. A decline of -147.73% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.06 of the overall float, the days-to-cover ratio (short ratio) decline to 0.06.
Which companies own the most shares of Xtant Medical Holdings Inc (XTNT)?
In terms of Xtant Medical Holdings Inc share price expectations, FactSet research, analysts set an average price target of 1.5 in the next 12 months, up nearly 150.0% from the previous closing price of $0.60. Analysts anticipate Xtant Medical Holdings Inc stock to reach 1.5 by 2025, with the lowest price target being 1.5. In spite of this, 4 analysts ranked Xtant Medical Holdings Inc stock as Buy at the end of 2025.
